Improvement of haemocompatibility of metallic stents by polymer coating

被引:75
|
作者
Lahann, J
Klee, D
Thelen, H
Bienert, H
Vorwerk, D
Höcker, H
机构
[1] Rhein Westfal TH Aachen, Dept Text & Macromol Chem, D-52062 Aachen, Germany
[2] Rhein Westfal TH Aachen, Fac Med, IZKF BIOMAT, D-52062 Aachen, Germany
[3] Rhein Westfal TH Aachen, Fac Med, Dept Radiol Sci, D-52062 Aachen, Germany
关键词
Polymer; Blood Flow; Chemical Vapor Deposition; Metal Surface; Surface Modification;
D O I
10.1023/A:1008939400812
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An alternative to open heart surgery in treating arterial diseases causing restricted blood flow is the implantation of intracoronary metallic stents. In spite of the advances in implantation and in spite of the excellent mechanical properties of metallic stents, there are still limitations because of the thrombogenicity of the metal. We have, hence, directed our attention to the coating of metallic stents with an ultrathin polymer layer by chemical vapor deposition (CVD) polymerization of 2-chloroparacyclophan. In a second step of surface modification the poly(2-chloroparaxylylene) layer is modified by treatment with a sulfur dioxide plasma in order to obtain a more hydrophilic surface with new functional groups. The results demonstrate the stable polymer coating of the stents and the improvement of haemocompatibility after treatment with sulfur dioxide plasma. Platelet adhesion is decreased from 85% for the metal surface to 20% for the CVD-coated and sulfur-dioxide-plasma treated surface. (C) 1999 Kluwer Academic Publishers.
引用
收藏
页码:443 / 448
页数:6
相关论文
共 50 条
  • [1] Improvement of haemocompatibility of metallic stents by polymer coating
    J. Lahann
    D. Klee
    H. Thelen
    H. Bienert
    D. Vorwerk
    H. Ho¨cker
    Journal of Materials Science: Materials in Medicine, 1999, 10 : 443 - 448
  • [2] Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents
    Mrowietz, C
    Franke, RP
    Seyfert, UT
    Park, JW
    Jung, F
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2005, 32 (02) : 89 - 103
  • [3] Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes
    Kastellorizios, Michail
    Michanetzis, Georgios P. A. K.
    Pistillo, Bianca Rita
    Mourtas, Spyridon
    Klepetsanis, Pavlos
    Favia, Piero
    Sardella, Eloisa
    d'Agostino, Ricardo
    Missirlis, Yannis F.
    Antimisiaris, Sophia G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 432 (1-2) : 91 - 98
  • [4] A BIOCOMPATIBLE PHOSPHATIDYLCHOLINE COATING APPLIED TO METALLIC STENTS
    NORDREHAUG, JE
    CHRONOS, N
    SIGWART, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A5 - A5
  • [5] Haemocompatibility of various polymer granulates
    Jung, F
    Mrowietz, C
    Seyfert, UT
    Franke, RP
    BIOMEDIZINISCHE TECHNIK, 1997, 42 (06): : 156 - 161
  • [6] Haemocompatibility of endovascular coronary stents:: Wiktor GX©
    Jung, F
    Bach, R
    Mrowietz, C
    Seyfert, U
    Franke, RP
    BIOMEDIZINISCHE TECHNIK, 2001, 46 (7-8): : 200 - +
  • [7] Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility
    Koromila, G
    Michanetzis, GPA
    Missirlis, YF
    Antimisiaris, SG
    BIOMATERIALS, 2006, 27 (12) : 2525 - 2533
  • [8] Bulk metallic glass coating of polymer substrates
    Soinila, Erno
    Sharma, Parmanand
    Heino, Markku
    Pischow, Kaj
    Inoue, Akihisa
    Hanninen, Hannu
    13TH INTERNATIONAL CONFERENCE ON RAPIDLY QUENCHED AND METASTABLE MATERIALS, 2009, 144
  • [9] Adhesion strength improvement of thermally sprayed metallic coating on carbon-fiber-reinforced polymer composite
    Pradhan, Sanjaya Kumar
    Kwon, Eui-Pyo
    Kweon, Lee Jong
    Oh, Min-Suk
    MATERIALS TODAY COMMUNICATIONS, 2024, 41
  • [10] Hydroxybutyl Chitosan Polymer-Mediated CD 133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis
    Li, Jian
    Zhang, Qiuwang
    Li, Dan
    An, Yi
    Kutryk, Michael B. J.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20 (03) : 322 - 329